Recent Updates
Recently added Catalysts

Abbreviated Zagreb 2-1-1 schedule

Phase 3

Rabies | Monoclonal antibody | Other |Novartis AG|Last Updated: Dec 13, 2011

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedACTIVE_CONTROLLED
Total Trials1
Total Enrollment825
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT00825305Safety and Immunogenicity (Non-inferiority) of a Purified Chick Embryo Cell Vaccine Vaccine Administered in Two Different Schedules (Conventional Versus Abbreviated Schedule)PHASE3 COMPLETED 825Nov 1, 2008Jan 1, 2009Dec 13, 20111 China
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Rabies Virus Neutralizing Antibody Concentrations on Day 14.
14 days

Rabies virus neutralizing antibody concentrations of the abbreviated Zagreb regimen compared with the conventional Essen regimen. Results are presented on log2 scale. For results on original geometric (multiplicative) scale please raise numbers to the basis of 2.

Number of Participants Who Reported a Local or Systemic Reaction After Any Vaccination
7 days after each vaccination

Specified local and systemic reactions were solicited for 7 days after each vaccination. Number of participants were calculated who reported a local or systemic reaction after any of the vaccinations.

Secondary Endpoints
Rabies Virus Neutralizing Antibody Concentrations on Day 7 and Day 42.
7 days and 42 days
Percentages of Participants With Seroconversion (Rabies Virus Neutralizing Antibody Concentrations Equal and Above 0.5 IU/ml) on Days 7, 14 and 42.
7 days, 14 days and 42 days
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposePREVENTION
Treatment Arms
ArmTypeDescription
Zagreb (2-1-1)EXPERIMENTALRabies PCEC vaccine was applied according Zagreb schedule with 2 vaccinations on day 0, 1 vaccination on day 7 and day 21, respectively
Essen (1-1-1-1-1)ACTIVE_COMPARATORRabies PCEC vaccine was applied according Essen schedule, i.e. 1 vaccination on day 0, day 3, day 7, day 14 and day 28, respectively.
Interventions
NameTypeDescription
Abbreviated Zagreb 2-1-1 scheduleBIOLOGICALSubjects received the abbreviated Zagreb 2-1-1 schedule in a safety-lead-in phase.
Standard Essen 1-1-1-1-1 scheduleBIOLOGICALSubjects received the standard Essen regimen.
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 50 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Male and female subjects 18-50 years of age who: * are in good health at the time of entry into the study as determined by medical history, physical examination and clinical judgment of the investigator; * volunteer for the simulated post-exposure vaccination courses and blood...

Countries:China
Unlock Eligibility Criteria